Cargando…

Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study

Introduction: The public health threat of substandard and falsified medicines has been well known in the last two decades, and several studies focusing on the identification of products affected and preventing consumption have been published. However, the number of these products reaching patients a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pozsgai, Kevin, Szűcs, Gergő, Kőnig-Péter, Anikó, Balázs, Orsolya, Vajda, Péter, Botz, Lajos, Vida, Róbert György
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485933/ https://www.ncbi.nlm.nih.gov/pubmed/36147337 http://dx.doi.org/10.3389/fphar.2022.964399

Ejemplares similares

Substandard and Falsified Medicines in Myanmar
por: Sakuda, Mirai, et al.
Publicado: (2020)

The Epidemic of Substandard and Falsified Medications in Iraq: Evaluating the Effectiveness of National Pharmacovigilance Alerts to Community Pharmacies
por: Al-Jumaili, Ali Azeez, et al.
Publicado: (2021)

Survey of workflow and cost implications of decommissioning regarding the Falsified Medicines Directive in Hungarian hospital pharmacies
por: Vajda, Péter, et al.
Publicado: (2021)

The economic impact of substandard and falsified antimalarial medications in Nigeria
por: Beargie, Sarah M., et al.
Publicado: (2019)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
por: Zabala, Guillermo A, et al.
Publicado: (2022)

Combatting Substandard and Falsified Medicines: A View from Rwanda
por: Binagwaho, Agnes, et al.
Publicado: (2013)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
por: Ferrario, Alessandra, et al.
Publicado: (2019)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
por: Rojas-Cortés, Robin
Publicado: (2020)

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
por: Jackson, Kathryn D., et al.
Publicado: (2020)

Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries
por: Kovacs, Stephanie, et al.
Publicado: (2014)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2022)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
por: Sweileh, Waleed M.
Publicado: (2021)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
por: El-Dahiyat, Faris, et al.
Publicado: (2021)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
por: Pisani, Elizabeth, et al.
Publicado: (2021)

Mobile apps for detecting falsified and substandard drugs: A systematic review
por: Ciapponi, Agustín, et al.
Publicado: (2021)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
por: Wada, Yusuf Hassan, et al.
Publicado: (2022)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
por: Cavany, Sean, et al.
Publicado: (2023)

Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines
por: Wang, Wenbo, et al.
Publicado: (2019)

Falsified and substandard cardiovascular drugs in Africa: a need for continued monitoring strategies
por: Antignac, Marie, et al.
Publicado: (2019)

The scourge of substandard and falsified medical products gets worse with COVID-19 pandemic
por: Shiferie, Fisseha, et al.
Publicado: (2020)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
por: Akpobolokemi, Tamara, et al.
Publicado: (2022)

Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador
por: Yakhkind, Aleksandra, et al.
Publicado: (2022)

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
por: Almuzaini, Tariq, et al.
Publicado: (2013)

Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention
por: Sylim, Patrick, et al.
Publicado: (2018)

Retracted and Republished: A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2019)

Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries
por: Hauk, Cathrin, et al.
Publicado: (2021)

A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives
por: Ahmed, Jamee, et al.
Publicado: (2022)

Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea
por: Kaur, Harparkash, et al.
Publicado: (2017)

Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
por: Rasheed, Huma, et al.
Publicado: (2018)

Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches
por: Ozawa, Sachiko, et al.
Publicado: (2022)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
por: Higgins, Colleen R., et al.
Publicado: (2023)

The response to substandard and falsified medical products in francophone sub-Saharan African countries: weaknesses and opportunities
por: Macé, Cécile, et al.
Publicado: (2023)

A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better
por: Tabernero, Patricia, et al.
Publicado: (2015)

Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy
por: Lawson, Graham, et al.
Publicado: (2018)

Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study
por: Ozawa, Sachiko, et al.
Publicado: (2019)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab
por: Petersen, Albert, et al.
Publicado: (2017)

Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo
por: Schäfermann, Simon, et al.
Publicado: (2020)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
por: Khurelbat, Daariimaa, et al.
Publicado: (2020)

Usefulness of combined screening methods for rapid detection of falsified and/or substandard medicines in the absence of a confirmatory method
por: Opuni, Kwabena Frimpong-Manso, et al.
Publicado: (2019)

Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
por: Chen, Hui-Han, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vticu8n798e4qf3fecpqn48i2b